This inventor holds 1 USPTO granted patent. Top assignee: Lonza Ag. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovations of Markus Rohner
Introduction
Markus Rohner is a notable inventor based in Kourim, Switzerland. He has made significant contributions to the field of chemistry, particularly in the preparation of nicotinamide. His innovative approach has led to the development of a unique process that enhances the efficiency of this important compound.
Latest Patents
Markus Rohner holds a patent for a process for preparing nicotinamide. This process involves several stages, starting with the catalytic conversion of 2-methyl-1,5-diaminopentane into 3-picoline. Following this, the 3-picoline undergoes ammonoxidation to become 3-cyanopyridine. Finally, the 3-cyanopyridine is microbiologically converted into nicotinamide. This innovative method showcases his expertise in chemical processes and his commitment to advancing the field.
Career Highlights
Markus Rohner is associated with Lonza AG, a leading global supplier to the pharmaceutical and biotechnology industries. His work at Lonza AG has allowed him to collaborate with other talented professionals in the field. His contributions have not only advanced his career but have also positively impacted the industry.
Collaborations
Some of Markus Rohner's notable coworkers include Hans-Rudolf Dettwiler and Roderick J Chuck. Their collaboration has fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Markus Rohner's innovative work in the preparation of nicotinamide exemplifies the impact of dedicated inventors in the field of chemistry. His contributions continue to influence the industry and inspire future innovations.